Maximum Retail Prices of Medicines
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
Notice to All Marketing Authorization Holders (MAHs)
Applications for products with Maximum Retail Prices (MRPs) approved on or before 31 May 2026 and after 1 February 2026 will be considered under this process.
MAHs seeking a revision of the Maximum Retail Price (MRP) due to a fluctuation of more than 5% in the average USD exchange rate published by the NMRA may submit their applications using the designated Google Form.
The revised MRP shall apply only to consignments imported after approval of the revised MRP.
MAHs who have already submitted applications in response to the previous notice are not required to reapply.
Thank you.
CEO NMRA
Please follow the procedure below when submitting an application:
1. Complete the designated Google Form and obtain a printed copy of the submitted form.
2. Complete and submit Form F-PD-002- "Submission of Price Details for a Maximum Retail Price (MRP) Revision Request (Medicines Applications)" (Effective Date: 12.09.2025/V1.0/Rev. No. 0), together with all relevant supporting documents. The form must bear the original signature of the responsible person.
3. Submit copies of the following documents:
4. Upon receipt of the email confirming the approved revised MRP, submit the original Import License to the Licensing Division, NMRA, within three (3) days of receipt of the email for the necessary amendments.
Click Here :
Notice to all Authorized Local Agents,
Average US Dollar Rate August -2026 for Price Approvals of MRP’s by NMRA
This is to kindly inform all authorized local agents that the USD rate considered for the month of August-2026 for processing price details of medicines/medical devices is 338.63.
Please ensure that all price submissions for MRP approvals are prepared accordingly.
To obtain list of Stop clock expired (2 months) applications, but sill not submitted requested additional documents and Still not received awaiting evaluation, from all MAH.
Regarding the product categories need to be considered under Aesthetic- related purpose
Click Here : for more information.
Notice to All Marketing Authorization Holders (MAHs)
Please be informed that the Public Day scheduled for Monday, 27 July 2026, at the Pricing Regulatory Division has been rescheduled to Tuesday, 28 July 2026, due to unavoidable circumstances.
We regret any inconvenience caused and appreciate your cooperation.
Thank You.
CEO, NMRA
